Hepatitis B Birth Dose AND feasibility OR "vaccine supply"
Al-Busafi, S. A., & Alwassief, A. (2024). Global perspectives on the hepatitis B vaccination: Challenges, achievements, and the road to elimination by 2030. Vaccines, 12(3), 288.https://doi.org/10.3390/vaccines12030288
Odhiambo, J. N., Dolan, C. B., Thompson, E., O’Neill, K., Sankok, J., & Kimani, R. (2025). Childhood vaccination trends among the Maasai nomadic pastoralists: Insights from a community-based vaccine registry in Kenya. PLOS Global Public Health, 5(3), e0004077.ttps://doi.org/10.1371/journal.pgph.0004077
Solomon-Rakiep, T., Olivier, J., & Amponsah-Dacosta, E. (2024). Towards contextualized complex systems approaches to scaling-up hepatitis B birth-dose vaccination in the African region: A qualitative systematic review. Frontiers in Public Health, 12, 1389633.https://doi.org/10.3389/fpubh.2024.1389633
Vo‐Quang, E., & Lemoine, M. (2024). Global elimination of HBV: Is it really achievable? Journal of Viral Hepatitis, 31, 4–12.https://doi.org/10.1111/jvh.13955
Wibowo, D. P., Agustiningsih, A., Jayanti, S., Sukowati, C. H., & El Khobar, K. E. (2024). Exploring the impact of hepatitis B immunoglobulin and antiviral interventions to reduce vertical transmission of hepatitis B virus. World Journal of Experimental Medicine, 14(4), 95960.doi: 10.5493/wjem.v14.i4.95960